KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/12/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization559,275 mln
Float3.03 mln
Earnings Date07/23/2025
EPS
14,104
Exceptional
P / E
5.82
Undervalued
Piotroski F-Score
9
/ 9
Exceptional
Beneish M-Score
-2.84
Likely reliable
Relative Strength
35
/ 100
Underperforming
Debt / Equity
0.57
Moderate leverage
Business Description
Dong-A Socio Holdings is a South Korea-based company founded in 1932 and headquartered in Seoul, operating across pharmaceuticals, healthcare, and a range of other industries. Its pharmaceutical work includes several drugs in clinical trials targeting conditions such as overactive bladder, obesity, and liver disease, alongside biosimilar and contract manufacturing services. Beyond healthcare, the company is involved in logistics, packaging, food and beverage production, real estate, and construction, among other activities.
